Prostamax

Buy Prostamax Online

Prostamax is a synthetic tetrapeptide composed of lysine, glutamic acid, aspartic acid, and proline (Lys-Glu-Asp-Pro). It belongs to the Khavinson short-peptide bioregulator family and is primarily associated with research involving prostate tissue, cellular differentiation, and age-related changes in prostatic function.

Product Information

Prostamax has been proposed as a tissue-specific peptide bioregulator targeting prostate-associated cellular processes. Research surrounding this peptide family has focused on tissue-specific gene expression and cellular differentiation, although direct evidence specifically establishing Prostamax's effects in humans remains limited.

The broader Khavinson peptide literature describes Prostamax as a prostate-associated tetrapeptide, but modern evidence reviews emphasize that direct human clinical evidence is sparse.

How It Works

The proposed mechanism of Prostamax involves short-peptide interactions with cellular regulatory systems, including chromatin and gene-expression processes. The tissue-specific bioregulator model proposes that these peptides may influence expression of genes associated with the target tissue, although the precise molecular mechanism remains incompletely established.

POTENTIAL BENEFITS

1. Prostate Research

Prostamax is primarily investigated in relation to prostate tissue and age-associated changes in prostatic function. This makes it relevant to research exploring peptide-based approaches to maintaining normal prostate-cell behavior.

2. Cellular Differentiation Research

The broader family of short tissue-specific peptides has demonstrated effects on differentiation-related gene expression in experimental models. Prostamax is therefore of interest in studies examining how peptide signals may influence tissue-specific cellular characteristics.

3. Prostate-Aging Research

Age-related changes in prostate tissue are an important area of biological research. Prostamax has been positioned within the peptide-bioregulator field as a compound for investigating how short peptides may influence aging-associated changes in prostate cells.

4. Gene-Expression Research

The proposed activity of Prostamax extends beyond conventional receptor signaling. Its research profile centers on potential effects on gene expression and chromatin regulation, providing a different model for investigating tissue-specific peptide signaling.

5. BPH-Related Research Interest

Prostamax is frequently discussed in connection with benign prostatic hyperplasia research. However, evidence directly demonstrating clinically meaningful effects in men with BPH remains insufficient, so this area should be regarded as a research interest rather than an established therapeutic benefit.

Dosage

There is no established human dosage for Prostamax.

Online peptide references may report amounts such as 20–40 mg/day, but these figures are not supported by robust clinical dose-finding studies and should be treated as reported market information rather than established medical dosing.

Side Effects

Human safety data are limited. Potential concerns include:

• Unknown long-term safety
• Individual sensitivity
• Possible gastrointestinal effects depending on administration
• Unknown interactions with medications

References

1. Khavinson VK, et al. Tissue-specific effects of peptides. PMID: 11713572. PubMed
2. Khavinson VK, et al. Mechanism of biological activity of short peptides. Research publication

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.